Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study
|
| Post date: 2025-11-07 00:50:41 |
| Views: 0 |
| The highest dose of Eli Lilly's weekly injection helped patients with obesity or who are overweight lose 20.1% of their body weight on average at 48 weeks. |
| Please click Here to read the full story. |
| |
| Other Top and Latest Questions: |
Answered: Hi, I need an upgrade guide.
|
Robinhood doubles revenue as it beats third-quarter earnings expectations
|
Tariffs face an uncertain future after Supreme Court hearing. Here are the potential market impacts
|
Family offices make fewer deals but still flock to AI startup mega-rounds
|
We're updating our rating and price target on a stock soaring after a spin-off
|
Here are Thursday's biggest analyst calls: Nvidia, Apple, Caterpillar, Qualcomm, Robinhood, Snap & more
|
AI startup Metropolis, biggest parking lot operator in U.S., raises $1.6 billion for major retail expansion
|
Peloton recalls 833,000 more bikes over seat post issue, two injuries reported
|
Trump may have to refund the tariffs. These stocks would benefit most
|
Target's sloppy stores are wearing on shoppers, and its turnaround could hinge on cleaning them up
|
Video
Web
Image
Music
BlogU
